Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Zydus Lifesciences reaffirmed high-teens FY27 growth ambitions and stable margins, highlighting the proposed Assertio acquisition and a wider pivot to specialty therapies, biosimilars and innovation-led R&D.
Indian benchmarks erased early gains and closed marginally lower as RBI rate-hike worries, inflation risks, weak manufacturing data and derivatives expiry volatility outweighed softer crude and a stronger rupee.
IRB Infrastructure rose up to 13% and Samvardhana Motherson gained about 5% on Thursday after strong quarterly updates, alongside multiple brokerage target revisions.
MD and CEO Gagan Banga says Sammaan Capital is targeting ₹35,000 crore FY27 disbursals, ₹1 lakh crore AUM, and higher profits via a rating upgrade.
Standard Chartered sees RBI rate hikes starting June amid crude-led inflation risks, while HSBC expects a June hold, highlighting a split view ahead of the June 5 decision.
RateGain Travel Technologies posted Q4FY25 total income of ₹276.86 crore and PAT of ₹50.02 crore, while FY25 operating revenue crossed ₹1,076.67 crore.
Embassy Developments is targeting ₹5,000 crore FY26 pre-sales, backed by Mumbai launches and strong Q3 momentum, after booking ₹1,999 crore in 9M FY26.
HFCL shares traded at Rs 139.34 on May 20, 2026, with the stock logging sharp FY27 gains and strong multi-period returns amid broader smallcap outperformance.
Anup Engineering has scheduled a February 3, 2026 board meeting to consider unaudited results for the period ended December 31, 2025, alongside a post-results investor call.
Stock market today saw a volatile finish with Sensex down 135 and Nifty almost flat, as oil near $105 and rate jitters capped early gains.
IGI India reported strong growth in natural and lab-grown diamond certification volumes, supported by stable LGD pricing, expanding service capacity, and rising demand for verified diamonds.
Emami reported record quarterly net sales and peak operating margin, but ROCE weakened and YoY PAT fell sharply, keeping sentiment cautious despite a small stock rise.
Triveni Turbine shares touched ₹707.40 on heavy volumes after the company flagged record Q4FY26 revenue and strong order momentum, with brokerages reiterating Buy calls.
Vedanta’s ex-demerger price reset, cost of acquisition split, and Q4FY26 results are in focus as investors track value across five focused businesses.
IOL Chemicals reported record Q4 FY26 revenue of ₹619.5 crore with sharply higher profit, while FY26 earnings rose and promoter holding increased to 57.48%.
Medplus Health shares rose as much as 11.3% after Q4FY26 profit grew to ₹63.97 crore and revenue increased 23.5% year-on-year to ₹1,864.39 crore.